Grifols, S.A EBITDA 2012-2019 | GRFS

Grifols, S.A annual and quarterly EBITDA history from 2012 to 2019. EBITDA can be defined as earnings before interest, taxes, depreciation and amortization.
  • Grifols, S.A EBITDA for the quarter ending June 30, 2019 was $0.356B, a 10.51% increase year-over-year.
  • Grifols, S.A EBITDA for the twelve months ending June 30, 2019 was $1.368B, a 8.34% increase year-over-year.
  • Grifols, S.A 2018 annual EBITDA was $1.444B, a 4.82% increase from 2017.
  • Grifols, S.A 2017 annual EBITDA was $1.378B, a 9.08% increase from 2016.
  • Grifols, S.A 2016 annual EBITDA was $1.263B, a 1.96% decline from 2015.
Grifols, S.A Annual EBITDA
(Millions of US $)
2018 $1,444
2017 $1,378
2016 $1,263
2015 $1,288
2014 $1,140
2013 $1,148
2012 $1,015
2011 $577
Grifols, S.A Quarterly EBITDA
(Millions of US $)
Q2 2019 $356
Q2 2018 $312
Q2 2017 $374
Q1 2017 $326
Q4 2016 $322
Q3 2016 $322
Q2 2016 $308
Q1 2016 $312
Q4 2015 $333
Q3 2015 $330
Q2 2015 $309
Q1 2015 $313
Q4 2014 $171
Q3 2014 $159
Q2 2014 $298
Q1 2014 $388
Q4 2013 $251
Q3 2013 $291
Q2 2013 $309
Q1 2013 $289
Q4 2012 $232
Q3 2012 $255
Q2 2012 $256
Q1 2012 $255
Q4 2011 $796
Q3 2011 $807
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $15.161B $5.299B
Grifols, S.A., operates in the pharmaceutical-hospital sector engaged in the research, development and retailing of plasma derivates, products for intravenous therapy, clinical nutrition, diagnostic and hospital logistics systems. The Company operates its business through three divisions: Bioscience Division, Diagnostic Division and Hospital Division. The Bioscience division is engaged in the research, development, production and commercialization of plasma derivates. Diagnostic Division focuses on researching, developing, manufacturing and marketing diagnostics products for laboratory analysis, including products for Hospital Blood Banks and Transfusion Centers. Hospital Division provides non-biological products used in hospital pharmacies, surgery, nutritional support, fluid therapy and for other therapeutic uses. Grifols, S.A. is based in Barcelona, Spain.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $60.196B 37.07
Astellas Pharma (ALPMY) Japan $26.780B 13.13
Takeda Pharmaceutical (TAK) Japan $26.201B 8.18
UCB SA (UCBJF) Belgium $15.008B 0.00
Eisai (ESALY) Japan $14.716B 25.30
Merck (MKGAF) Germany $13.654B 18.63
Ionis Pharmaceuticals (IONS) United States $9.973B 21.51
Ono Pharmaceutical (OPHLF) Japan $9.383B 20.06
Neurocrine Biosciences (NBIX) United States $8.886B 0.00
IPSEN SA ADR (IPSEY) France $8.634B 0.00
Sage Therapeutics (SAGE) United States $8.507B 0.00
Catalent (CTLT) United States $8.127B 32.61
Jazz Pharmaceuticals (JAZZ) Ireland $7.726B 10.17
Recordati Industria Chimica E Farmaceutica S.P.A (RCDTF) Italy $7.257B 19.83
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $5.781B 0.00
STADA ARZNEIMI (STDAF) Germany $5.547B 0.00
Orion OYJ (ORINY) Finland $5.275B 27.16
Hypermarcas (HYPMY) Brazil $4.954B 17.81
FibroGen (FGEN) United States $3.877B 96.98
United Therapeutics (UTHR) United States $3.565B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $3.197B 73.30
Taro Pharmaceutical Industries (TARO) Israel $3.140B 11.25
Evotec AG (EVTCY) Germany $3.032B 41.51
Nektar Therapeutics (NKTR) United States $2.999B 0.00
Tilray (TLRY) Canada $2.849B 0.00
PTC Therapeutics (PTCT) United States $2.695B 0.00
Xencor (XNCR) United States $2.309B 50.35
Zogenix (ZGNX) United States $2.148B 0.00
Portola Pharmaceuticals (PTLA) United States $1.974B 0.00
Pacira Pharmaceuticals (PCRX) United States $1.580B 57.50
CLINIGEN GP (CLIGF) United Kingdom $1.577B 0.00
USANA Health Sciences (USNA) United States $1.491B 14.95
Corcept Therapeutics (CORT) United States $1.468B 20.17
Heron Therapeutics (HRTX) United States $1.437B 0.00
Enanta Pharmaceuticals (ENTA) United States $1.424B 23.49
Ironwood Pharmaceuticals (IRWD) United States $1.380B 0.00
Theravance Biopharma (TBPH) Cayman Islands $1.218B 0.00
ArQule (ARQL) United States $1.110B 0.00
Radius Health (RDUS) United States $1.059B 0.00
Aerie Pharmaceuticals (AERI) United States $1.034B 0.00
Spectrum Pharmaceuticals (SPPI) United States $0.919B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $0.828B 3.69
Endo (ENDP) Ireland $0.684B 1.20
TherapeuticsMD (TXMD) United States $0.661B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.636B 0.00
Indivior (INVVY) United States $0.575B 2.08
Karyopharm Therapeutics (KPTI) United States $0.572B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $0.540B 0.00
Akebia Therapeutics (AKBA) United States $0.534B 0.00
Dermira (DERM) United States $0.482B 0.00
Concordia (CXRXF) Canada $0.479B 0.00
Aptorum Group (APM) China $0.464B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.457B 0.00
Translate Bio (TBIO) United States $0.443B 0.00
Dova Pharmaceuticals (DOVA) United States $0.429B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.427B 19.43
ChemoCentryx (CCXI) United States $0.410B 0.00
ImmunoGen (IMGN) United States $0.409B 0.00
Flexion Therapeutics (FLXN) United States $0.407B 0.00
Siga Technologies (SIGA) United States $0.405B 0.95
Organogenesis Holdings (ORGO) United States $0.400B 0.00
Collegium Pharmaceutical (COLL) United States $0.397B 0.00
Innate Pharma SA (IPHYF) France $0.374B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.365B 0.00
CV Sciences (CVSI) United States $0.340B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.323B 0.00
Xeris Pharmaceuticals (XERS) United States $0.314B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.296B 0.00
KalVista Pharmaceuticals (KALV) United States $0.290B 0.00
Rafael Holdings (RFL) United States $0.282B 0.00
Harpoon Therapeutics (HARP) United States $0.280B 0.00
CannTrust Holdings (CTST) Canada $0.277B 0.00
Lannett Co Inc (LCI) United States $0.277B 2.69
La Jolla Pharmaceutical (LJPC) United States $0.270B 0.00
DURECT (DRRX) United States $0.263B 0.00
OptiNose (OPTN) United States $0.263B 0.00
Recro Pharma (REPH) United States $0.259B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.251B 0.00
Concert Pharmaceuticals (CNCE) United States $0.246B 0.00
Ocular Therapeutix (OCUL) United States $0.218B 0.00
Calithera Biosciences (CALA) United States $0.213B 0.00
Ardelyx (ARDX) United States $0.197B 0.00
Molecular Templates (MTEM) United States $0.185B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.183B 0.00
Foamix Pharmaceuticals (FOMX) Israel $0.177B 0.00
Nature's Sunshine Products (NATR) United States $0.175B 29.26
Taiwan Liposome (TLC) Taiwan $0.171B 0.00
Redhill Biopharma (RDHL) Israel $0.155B 0.00
GlycoMimetics (GLYC) United States $0.146B 0.00
IMV INC (IMV) Canada $0.145B 0.00
Generex Biotechnology (GNBT) United States $0.137B 0.00
Majesco Entertainment (PTE) United States $0.133B 0.00
Jounce Therapeutics (JNCE) United States $0.123B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.121B 0.00
MEI Pharma (MEIP) United States $0.120B 0.00
Oasmia Pharmaceutical AB (OASM) Sweden $0.114B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.111B 0.00
Matinas Biopharma Holdings (MTNB) United States $0.108B 0.00
ALLERGY THERAPT (AGYTF) United Kingdom $0.108B 0.00
AgeX Therapeutics (AGE) United States $0.101B 0.00
Cardiome Pharma (CORV) Canada $0.097B 0.00
Mast Therapeutics (SVRA) United States $0.096B 0.00
Aquestive Therapeutics (AQST) United States $0.095B 0.00
Neos Therapeutics (NEOS) United States $0.094B 0.00
Iterum Therapeutics (ITRM) Ireland $0.094B 0.00
Nivalis Therapeutics (ALPN) United States $0.089B 0.00
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.086B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.083B 31.94
Genocea Biosciences (GNCA) United States $0.083B 0.00
MediWound (MDWD) Israel $0.080B 0.00
RENEURON GP (RNUGF) United Kingdom $0.080B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.078B 0.00
Natural Alternatives (NAII) United States $0.075B 7.52
Otonomy (OTIC) United States $0.072B 0.00
China SXT Pharmaceuticals (SXTC) China $0.071B 0.00
Champions Oncology (CSBR) United States $0.068B 589.00
Infinity Pharmaceuticals (INFI) United States $0.068B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.066B 0.00
Novan (NOVN) United States $0.063B 0.00
SCYNEXIS (SCYX) United States $0.062B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.060B 0.00
Pharmaxis (PXSLY) Australia $0.060B 0.00
Capnia (SLNO) United States $0.060B 0.00
Lipocine (LPCN) United States $0.060B 0.00
Medicure (MCUJF) Canada $0.053B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.053B 0.00
ElectroCore (ECOR) United States $0.050B 0.00
Forward Pharma (FWP) Denmark $0.044B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.044B 0.00
India Globalization Capital (IGC) United States $0.040B 0.00
CTI BioPharma (CTIC) United States $0.040B 0.00
Aclaris Therapeutics (ACRS) United States $0.040B 0.00
Mannatechorporated (MTEX) United States $0.036B 0.00
Bio-Path Holdings (BPTH) United States $0.036B 0.00
Melinta Therapeutics (MLNT) United States $0.034B 0.00
PharmAthene (ALT) United States $0.033B 0.00
Biomerica (BMRA) United States $0.028B 0.00
ProPhase Labs (PRPH) United States $0.023B 0.00
Opexa Therapeutics (ACER) United States $0.023B 0.00
IsoRay (ISR) United States $0.023B 0.00
Heat Biologics (HTBX) United States $0.019B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.018B 1.44
HANCOCK JAFFE (HJLI) United States $0.018B 0.00
Tetraphase Pharmaceuticals (TTPH) United States $0.015B 0.00
Achieve Life Sciences (ACHV) United States $0.015B 0.00
Cyanotech (CYAN) United States $0.015B 0.00
NovaBay Pharmaceuticals (NBY) United States $0.014B 0.00
Onconova Therapeutics (ONTX) United States $0.014B 0.00
Shineco (TYHT) China $0.013B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.012B 0.00
Regulus Therapeutics (RGLS) United States $0.012B 0.00
VAXART, INC (VXRT) United States $0.010B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.009B 0.00
RXi Pharmaceuticals (PHIO) United States $0.009B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.007B 0.00
Jaguar Animal Health (JAGX) United States $0.006B 0.00
Flex Pharma (SLRX) United States $0.005B 0.00
Midatech Pharma (MTP) United Kingdom $0.004B 0.00
Can-Fite Biopharma (CANF) Israel $0.003B 0.00
Cytori Therapeutics Inc (PSTV) United States $0.003B 0.00
Xenetic Biosciences (XBIO) United States $0.002B 0.00
Advanced Accelerator Applications S.A (AAAP) France $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00